Page last updated: 2024-08-21

c.i. 42510 and Astrocytoma, Grade IV

c.i. 42510 has been researched along with Astrocytoma, Grade IV in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, T; Huang, Y; Jungblut, PR; Li, J; Li, M; Li, N; Li, Z; Liu, J; Long, Y; Lu, M; Mu, Y; Peng, F; Yang, H; Zhan, X1
Li, A; Liu, T; Xin, Y; Xu, Y1
Brotchi, J; Camby, I; Decaestecker, C; Dewitte, O; Kiss, R; Pasteels, JL; Salmon, I; Van Ham, P1
Camby, I; Cras, P; Decaestecker, C; Gordower, L; Kiss, R; Lopes, BS; Martin, JJ; Salmon, I; VandenBerg, SR1
Korek, G; Martin, H; Wenzelides, K1
Bojinov, S; Ivanova, A; Lolova, I1

Other Studies

6 other study(ies) available for c.i. 42510 and Astrocytoma, Grade IV

ArticleYear
How many proteins can be identified in a 2DE gel spot within an analysis of a complex human cancer tissue proteome?
    Electrophoresis, 2018, Volume: 39, Issue:7

    Topics: Adenoma; Adult; Electrophoresis, Gel, Two-Dimensional; Glioblastoma; Humans; Isotope Labeling; Male; Pituitary Neoplasms; Proteome; Retinoblastoma; Rosaniline Dyes; Tandem Mass Spectrometry

2018
MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo.
    Cancer medicine, 2019, Volume: 8, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Glioblastoma; Humans; Mice, Inbred BALB C; Mice, Nude; Rosaniline Dyes; Temozolomide

2019
Nearest-neighbor classification for identification of aggressive versus nonaggressive low-grade astrocytic tumors by means of image cytometry-generated variables.
    Journal of neurosurgery, 1997, Volume: 86, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Astrocytoma; Cell Nucleus; Coloring Agents; Diagnosis, Differential; Discriminant Analysis; DNA, Neoplasm; Female; Flow Cytometry; Glioblastoma; Humans; Image Processing, Computer-Assisted; Male; Microscopy; Middle Aged; Neoplasm Invasiveness; Pattern Recognition, Automated; Ploidies; Rosaniline Dyes; Supratentorial Neoplasms; Survival Analysis; Survival Rate

1997
Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas.
    Journal of neuropathology and experimental neurology, 1997, Volume: 56, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Astrocytes; Astrocytoma; Cell Nucleus; Chromatin; Coloring Agents; Diagnosis, Differential; Discriminant Analysis; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Oligodendroglia; Oligodendroglioma; Rosaniline Dyes; Staining and Labeling

1997
A modified method for the detection of nucleolar organizer regions (AgNORs).
    Acta histochemica, 1991, Volume: 90, Issue:2

    Topics: Animals; Astrocytoma; Coloring Agents; Glioblastoma; Histocytochemistry; Humans; In Vitro Techniques; Liver; Nucleolus Organizer Region; Rats; Rosaniline Dyes; Silver; Staining and Labeling; Urinary Bladder Neoplasms

1991
Histochemical investigation of nonspecific acid phosphatase in cerebral tumors.
    Journal of neurosurgery, 1971, Volume: 34, Issue:6

    Topics: Acid Phosphatase; Adenoma, Chromophobe; Astrocytoma; Biopsy; Brain Neoplasms; Choroid Plexus; Ependymoma; Glioblastoma; Hemangiosarcoma; Histocytochemistry; Humans; Medulloblastoma; Meningioma; Neurilemmoma; Oligodendroglioma; Papilloma; Pituitary Neoplasms; Rosaniline Dyes; Sarcoma; Staining and Labeling

1971